Therapeutic Human Monoclonal Antibodies Against Cancer
There are over 30 monoclonal antibodies that are FDA approved for a variety of diseases ranging from malignancies to autoimmune diseases to macular degeneration. These antibodies include murine, fully humanized, and chimeric antibodies. There are a number of monoclonal antibodies used in the treatment of malignancies; in fact, three of the top five grossing antibodies (bevacizumab, trastuzumab, and rituximab) are used in oncology Scolnik (mAbs 1:179–184, 2009).
Source: Springer protocols feed by Immunology - Category: Allergy & Immunology Source Type: news
More News: Allergy & Immunology | Autoimmune Disease | Avastin | Cancer | Cancer & Oncology | Herceptin | Rituxan